Sangamo Therapeutics, Inc
Ticker: SGMO
| Insider | Title |
|---|---|
| Amy Pooler | VP, HEAD OF RESEARCH |
| Courtney Beers | Director |
| David Mark Mcclung | EVP, Chief Operating Officer |
| Gregory D Davis | Head of Research Technology |
| H Stewart Parker | Director |
| Inc. Biogen | 10% or greater ownership |
| James R Meyers | Director |
| Jason D. Fontenot | SVP, Chief Scientific Officer |
| John Markels | Director |
| Joseph S Zakrzewski | Director |
| Karen L. Smith | Director |
| Kenneth J. Hillan | Director |
| Ma Inc. Biogen | 10% or greater ownership |
| Margaret A Horn | Director |
| Nathalie Dubois-stringfellow | SVP-CHIEF DEVELOPMENT OFFICER |
| Prathyusha Duraibabu | SVP, CHIEF FINANCIAL OFFICER |
| Robert Carey | Director |
| Robert J. Schott | SVP, Head of Development |
| Rolf Andrew Ramelmeier | EVP, Technical Operations |
| Saira Ramasastry | Director |
| Sandy Macrae | PRESIDENT, CEO AND DIRECTOR, Director |
| Scott B. Willoughby | SVP, GEN. COUNSEL SECRETARY |